Vivo Capital, LLC Q4 2022 Filing
Filed February 13, 2023
Portfolio Value
$868.5B
Holdings
48
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $143.6B | 16.53% | |
| 2 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $67.8B | 7.80% | |
| 3 | VRDNViridian Therapeutics Inc | 1,678,207 | $49.0B | 5.64% | |
| 4 | ALXOALX Oncology Holdings Inc | 4,220,048 | $47.6B | 5.48% | |
| 5 | GONGeron Corp | 19,282,834 | $46.7B | 5.37% | |
| 6 | —Impel NeuroPharma Inc | 2,884,789 | $43.3B | 4.98% | |
| 7 | VTYXVentyx Biosciences Inc | 1,303,294 | $42.7B | 4.92% | |
| 8 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 4.40% | |
| 9 | ALLKGUSDAllakos Inc | 4,120,134 | $34.7B | 3.99% | |
| 10 | TARSTarsus Pharmaceuticals Inc | 2,262,200 | $33.2B | 3.82% | |
| 11 | PCVXVaxcyte Inc | 579,508 | $27.8B | 3.20% | |
| 12 | CATBUSDAstria Therapeutics Inc | 1,681,199 | $25.0B | 2.88% | |
| 13 | COGTCogent Biosciences Inc | 1,994,941 | $23.1B | 2.66% | |
| 14 | 290AChinook Therapeutics Inc | 872,151 | $22.9B | 2.63% | |
| 15 | —VectivBio Holding AG | 2,333,300 | $20.2B | 2.33% | |
| 16 | AVDLAvadel Pharmaceuticals PLC | 2,754,095 | $19.7B | 2.27% | |
| 17 | CMPXCompass Therapeutics Inc | 3,557,630 | $17.9B | 2.06% | |
| 18 | ACRSAclaris Therapeutics, Inc. | 898,631 | $14.2B | 1.63% | |
| 19 | LEGNLegend Biotech Corp Sponsored | 244,375 | $12.2B | 1.40% | |
| 20 | AMRSEURAmyris, Inc | 7,750,828 | $11.9B | 1.37% | |
| 21 | ZLABZai Lab Ltd ADR | 338,721 | $10.4B | 1.20% | |
| 22 | —Genetron Holdings Ltd | 8,124,174 | $9.1B | 1.05% | |
| 23 | BLUBellus Health Inc | 1,017,152 | $8.4B | 0.96% | |
| 24 | TILInstil Bio Inc | 12,486,787 | $7.9B | 0.91% | |
| 25 | VERAVera Therapeutics Inc | 400,666 | $7.8B | 0.89% | |
| 26 | IOBTIO Biotech Inc | 3,015,545 | $6.9B | 0.80% | |
| 27 | MRUSMerus NV | 438,590 | $6.8B | 0.78% | |
| 28 | DYNDyne Therapeutics Inc | 577,642 | $6.7B | 0.77% | |
| 29 | WHWKAadi Bioscience Inc | 509,572 | $6.5B | 0.75% | |
| 30 | KALVKalVista Pharmaceuticals Inc. | 856,008 | $5.8B | 0.67% | |
| 31 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $5.6B | 0.64% | |
| 32 | BCABBioAtla Inc | 637,181 | $5.3B | 0.61% | |
| 33 | —Cincor Pharma Inc | 421,635 | $5.2B | 0.60% | |
| 34 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $5.0B | 0.58% | |
| 35 | IOVAIovance Biotherapeutics Inc | 655,057 | $4.2B | 0.48% | |
| 36 | —DBV Technologies SA | 2,708,875 | $4.1B | 0.48% | |
| 37 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $4.1B | 0.48% | |
| 38 | VRNAVerona Pharma PLC | 4,249,918 | $3.6B | 0.42% | |
| 39 | ALGSAligos Therapeutics Inc | 3,547,030 | $3.4B | 0.39% | |
| 40 | SERASera Prognostics Inc | 1,856,011 | $2.3B | 0.27% | |
| 41 | GRCLGracell Biotechnologies Inc | 961,358 | $2.2B | 0.25% | |
| 42 | CDXSCodexis, Inc | 388,144 | $1.8B | 0.21% | |
| 43 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $1.0B | 0.12% | |
| 44 | RZLTRezolute Inc | 489,473 | $1.0B | 0.12% | |
| 45 | IMUXImmunic Inc | 632,184 | $833.0M | 0.10% | |
| 46 | —Minerva Surgical Inc | 2,215,667 | $495.0M | 0.06% | |
| 47 | FIXXEURHomology Medicines, Inc. | 370,068 | $466.0M | 0.05% | |
| 48 | DTILPrecision Biosciences Inc | 140,255 | $167.0M | 0.02% |